Regeneron Pharmaceuticals' IPO

Regeneron Pharmaceuticals raised a round of funding on , . Investors include Public.

Regeneron Pharmaceuticals is a science-based biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. Reg…

Articles about Regeneron Pharmaceuticals' IPO: